Did you know?
You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)
With so many trials lining up waiting to start, that could very well be the cause for the delay. Even though the case for ABL is sovstrong, and no doubt much stronger than most other drugs, I don't think that would enable RVX to jump the queue. If a "yogurt trial" was already signed up before ABL in the same clinical center, RVX would have to wait until it was finished.
